Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Still Nervous Short Term

Published 10/31/2014, 10:08 AM
Updated 07/09/2023, 06:31 AM

McClellan OB/OS Oscillators Remain Overbought

Opinion

The futures are implying a strong open this morning but we cannot shake the feeling that the recent rally may be nearing its peak based on internal volume characteristics, overbought conditions, deterioration in psychology and near term valuations.

  • On the charts, most of the indexes closed higher on the day with the DJT (page 3) being the outlier as it closed lower and below its nearly vertical uptrend line. The weakness in the DJT may not be “significant” but we would note it was the index that lead the recent rally. Thus, it may be the first to see its short term peak. Today’s action in the DJT will give better insight as to whether or not this is the case. The SPX (page 2) closed above resistance while the COMPQX (page 3) and RUT (page 4) closed just below their resistance levels that will likely be broken on the open.
  • Our only other observation worthy of note was the decline in trading volumes once again as the markets advanced. We mention it only because we saw similar volume activity prior to the correction at the beginning of the month.
  • Looking at the data, there are several points of concern, in our opinion. The McClellan OB/OS Oscillators are mostly overbought with the NYSE 1 day extremely so at +101.54. Its 21 day is an overbought +54.17 with the NASDAQ 1 day overbought at +97.26. Its 21 day is a neutral +34.34. So the OB/OS suggest a significant drop in “fuel” to carry the markets higher. The WST Ratio and its Composite are on glaring red lights at 67.3 and 277.3 while the Equity Put/Call Ratio has turned to a neutral .58.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • Psychology has deteriorated as the “crowd” has quickly forgotten its recent sufferings with a very cautionary 56.8 Rydex Ratio (contrary indicator) and the new AAII Bear/Bull Ratio (contrary indicator) turning negative to 21.07/49.37.
  • Although not a “technical event”, we believe valuation is again a concern as forward 12 month EPS estimates for the SPX that have recently declined to $127.58 from $129.05 leaves the forward P/E at a decade high of 15.6X. So although the SPX is near its prior high, it is now more expensive than prior to the correction.
  • In conclusion, we remain nervous regarding the short term market prospects.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.